Award

NIH Reporter #1R21AI199907-01

Anopheles salivary antigen to measure the effectiveness of permethrin-treated baby wraps for the prevention of malaria: secondary analysis of a randomized controlled trial.

Recipient

UNIV OF NORTH CAROLINA CHAPEL HILL, CHAPEL HILL, NC, UNITED STATES

Award Amount

$433,977.00

Ceiling

$433,977.00

Awarded

August 10, 2026

Identifier

1R21AI199907-01

The study tests human antibodies against Anopheles mosquito salivary antigens to confirm the protective effect of permethrin-treated baby wraps against malaria in children, based on a prior randomized trial in Uganda.

Description

This project involves analyzing blood samples for antibody responses to mosquito salivary antigens as a surrogate for mosquito exposure, aiming to confirm the mechanism of malaria prevention via permethrin-treated wraps and to validate a novel biomarker for malaria-related studies.

View original record